Recursion Pharmaceuticals
RXRX
#5022
Rank
HK$14.17 B
Marketcap
HK$26.83
Share price
-1.01%
Change (1 day)
-38.12%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: HK$14.17 Billion

As of May 2026 Recursion Pharmaceuticals has a market cap of HK$14.17 Billion. This makes Recursion Pharmaceuticals the world's 5022th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$14.17 B-17.78%
2025HK$17.23 B-23.11%
2024HK$22.41 B34.85%
2023HK$16.62 B45.58%
2022HK$11.41 B-49.41%
2021HK$22.57 B

End of Day market cap according to different sources

On Apr 30th, 2026 the market cap of Recursion Pharmaceuticals was reported to be:

HK$14.29 Billion
by Nasdaq info icon info icon
HK$14.31 Billion
by CompaniesMarketCap info icon info icon